Equities

IFR US ECM PRICINGS

| Robert Sherwood

D Boral Arc Acquisition I (BVI, SPAC) ─ $250m IPO. 25m units (Primary) at $10.00. Each unit comprises one share and one-half warrant. DBORAL. Nasdaq “BCARU”. David Boral/John Darwin. Not defined. 18 months. 100% in trust.

Figma (US, digital design software) ─ $1.22bn IPO. 36.9m shares (Primary, Secondary) at $33.00 versus $30-$32 marketing. MS, GS, ALLN, JPM. NYSE “FIG”. Price range increased from $25-$28 on 7/28.

Prime Medicine (US, biotech) ─ $125.4m ABB. 38m shares (Primary) at $3.30 versus $3.25-$3.50 marketing and $3.92 last sale. TDC, BMO. Upsized from $100m. Wall cross.

Shoulder Innovations (US, medical devices) ─ $75m IPO. 5m shares (Primary) at $15.00 versus $19-$21 marketing. MS, GS, PS. NYSE "SI".

Topics

Americas North America United States Equity Capital ABBs and Block Trades Latin America Caribbean British Virgin Islands Initial Public Offerings (IPO) Marketed Follow-Ons US Dollar

Issuers

Figma Inc Prime Medicine Inc (PRME.O) Shoulder Innovations Inc